Disability-Adjusted Life Year (DALY)
Also known as: DALY, global disease burden metric, burden of disease
A DALY quantifies disease burden as the sum of years of life lost to premature death and years lived with disability. Developed by the World Health Organization and World Bank in 1990 as part of the Global Burden of Disease (GBD) study, DALYs enable epidemiologists and public health planners to compare disease burden across populations, identify health priorities, and evaluate intervention impact. One DALY = one lost year of 'healthy' life; DALYs averted measure progress toward health goals.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
When estimating population health burden (what diseases matter most?). DALY is the standard metric for WHO, national health ministries, and global health organizations (Gates Foundation, Gavi, etc.). Use when: comparing disease burden across countries or regions; tracking progress over time; prioritizing research funding; designing national health plans; evaluating public health interventions (vaccination programs, sanitation, health promotion); reporting health equity (DALYs by socioeconomic status or geography). Not appropriate for: assessing individual patient outcomes (use QALY); cost-benefit analysis at detailed clinical level; modeling non-health outcomes (employment, education).
Strengths & limitations
- Unifies mortality and morbidity into one metric, enabling direct comparison of burden from fatal vs disabling diseases on a single priority scale.
- Grounded in epidemiological data: DALYs are derived from observed incidence, prevalence, and mortality, not theoretical assumptions.
- Globally standardized: GBD study provides comparable DALY estimates across 195 countries, facilitating international benchmarking and equity analysis.
- Supports evidence-based policy: national health ministries use DALY burden rankings to allocate budgets, design guidelines, and communicate health priorities to public and donors.
- Disability weights are subjective: lay panel valuations often differ from patient experience; assigning 0.4 weight to blindness may not reflect how blind persons value their quality of life.
- Discounting and age weighting are controversial: standard 3% discount rate is arbitrary; age weighting (pre-2010 GBD) undervalued elder health, now widely criticized as ageist.
- DALYs assume disease duration and disability are fixed: does not account for heterogeneity within diagnoses (some asthmatics severely disabled, others minimally) or natural remission.
- Comorbidity not explicitly modeled: a person with both diabetes and depression is counted as two separate DALY streams; interaction effects ignored.
- Large uncertainty in low-income countries: sparse epidemiological data leads to reliance on modeling and assumptions; DALY estimates carry wide confidence intervals, yet reported as point estimates.
Frequently asked
What is the standard life expectancy used in DALY calculations?
GBD 2010 and later versions use a reference life expectancy based on lowest observed death rates at each age globally (essentially Japanese female life expectancy, with adjustments for recent improvements). This ensures consistent YLL calculation across countries, regardless of local life tables. This is a methodological choice to enable comparability; some high-income countries use local life expectancy.
How are disability weights determined for new or rare diseases?
GBD expert panels conduct systematic reviews of clinical literature and patient reports, then weight health states. For very rare conditions, weights may be inferred from similar conditions or elicited through limited surveys. Uncertainty is high; confidence intervals are wide. As more evidence accumulates (patient registries, published health utility studies), weights are revised.
Why does GBD 2010 remove age weighting when earlier versions used it?
Age weighting privileged 'productive years' (15–50), assigning lower weight to childhood and elderly. This was criticized as ageist and contrary to human rights principles (a child's life is not worth less). GBD 2010 and later versions use uniform age weighting (all years of healthy life valued equally), aligning with ethical norms and social preferences in most high-income countries.
How are comorbidities handled if a person has multiple conditions?
Standard DALY approach sums YLD contributions from each condition separately. This can lead to double-counting (a person with diabetes + depression counted as two YLD streams). More sophisticated approaches use joint disability weights or hierarchical modeling (e.g., the worse disability takes precedence), but these are not standard in GBD. Users should note that DALY sums assume independence.
What is the difference between incidence-based and prevalence-based DALYs?
Incidence-based: DALY counts a cohort from disease onset until recovery/death (follows incident cases forward). Prevalence-based: counts current persons with disease, multiplying by annual disability weight. Incidence-based DALYs align with cohort follow-up and interventions (e.g., vaccination prevents future DALYs). Prevalence-based DALYs reflect current healthcare burden. GBD primarily uses prevalence-based for YLD, but outcomes vary by disease.
Can DALYs be negative, or can an intervention create DALYs?
No. DALYs are always ≥0; higher DALYs = more burden. An intervention cannot create DALYs (it averts them or has no effect). However, an intervention with adverse effects (e.g., medication side effects) can reduce the DALY averted or even increase overall burden if side effects outweigh benefits.
Sources
- Murray, C. J., Lopez, A. D., & Jamison, D. T. (1994). The Global Burden of Disease in 1990: Summary Results, Sensitivity Analysis, and Future Directions. In C. J. Murray & A. D. Lopez (Eds.), Global Burden of Disease and Injury. Cambridge: Harvard University Press. link ↗
- Global Burden of Disease Study 2019 Collaborators. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204-1222. link ↗
- Mathers, C. D., Vos, T., & Lopez, A. D. (2003). The Burden of Disease and Injury in Australia. Public Health Division, Department of Health and Ageing, Australian Government. link ↗
How to cite this page
ScholarGate. (2026, June 4). Disability-Adjusted Life Year (DALY). ScholarGate. https://scholargate.app/en/health-economics/disability-adjusted-life-year
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Cost-Effectiveness AnalysisHealth Economics↔ compare
- Decision Analytic ModelingHealth Economics↔ compare
- Markov Model in Health EconomicsHealth Economics↔ compare
- Quality-Adjusted Life YearHealth Economics↔ compare
- Willingness to Pay in HealthHealth Economics↔ compare